KR950700282A - S-트리아진 유도체 및 이를 활성성분으로서 함유하는 에스트로겐-의존성 질환 치료제(s-Triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient) - Google Patents
S-트리아진 유도체 및 이를 활성성분으로서 함유하는 에스트로겐-의존성 질환 치료제(s-Triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient)Info
- Publication number
- KR950700282A KR950700282A KR1019940703005A KR19940703005A KR950700282A KR 950700282 A KR950700282 A KR 950700282A KR 1019940703005 A KR1019940703005 A KR 1019940703005A KR 19940703005 A KR19940703005 A KR 19940703005A KR 950700282 A KR950700282 A KR 950700282A
- Authority
- KR
- South Korea
- Prior art keywords
- estrogen
- remedy
- active ingredient
- same
- triazine derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7844992 | 1992-02-28 | ||
| PCT/JP1993/000240 WO1993017009A1 (fr) | 1992-02-28 | 1993-02-26 | DERIVE DE s-TRIAZINE ET REMEDE CONTRE DES MALADIES DEPENDENTES DE L'×STROGENE LE CONTENANT COMME INGREDIENT ACTIF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR950700282A true KR950700282A (ko) | 1995-01-16 |
Family
ID=13662350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019940703005A Abandoned KR950700282A (ko) | 1992-02-28 | 1994-08-27 | S-트리아진 유도체 및 이를 활성성분으로서 함유하는 에스트로겐-의존성 질환 치료제(s-Triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient) |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5489591A (enExample) |
| EP (1) | EP0629622B1 (enExample) |
| KR (1) | KR950700282A (enExample) |
| AU (1) | AU665238B2 (enExample) |
| CA (1) | CA2131004A1 (enExample) |
| DE (1) | DE69322076D1 (enExample) |
| WO (1) | WO1993017009A1 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6432947B1 (en) | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
| JP2002509140A (ja) * | 1998-01-13 | 2002-03-26 | アナディーズ・ファーマスーティカルズ，インコーポレイテッド | トリアジン抗ウイルス化合物 |
| US6335339B1 (en) | 1998-01-13 | 2002-01-01 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| US6943161B2 (en) * | 1999-12-28 | 2005-09-13 | Pharmacopela Drug Discovery, Inc. | Pyrimidine and triazine kinase inhibitors |
| US6525051B2 (en) | 2000-03-27 | 2003-02-25 | Schering Aktiengesellschaft | N-heterocyclic derivatives as NOS inhibitors |
| AU5969101A (en) | 2000-05-12 | 2001-11-26 | Genzyme Corp | Modulators of tnf-alpha signaling |
| WO2002047690A1 (en) * | 2000-12-12 | 2002-06-20 | Cytovia, Inc. | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| US6716851B2 (en) | 2000-12-12 | 2004-04-06 | Cytovia, Inc. | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
| US6943162B2 (en) | 2001-01-26 | 2005-09-13 | Smithkline Beecham Corporation | Piperazinyltriazines as estrogen receptor modulators |
| ATE350376T1 (de) | 2001-04-27 | 2007-01-15 | Zenyaku Kogyo Kk | Heterocyclische verbindung und antitumormittel, das diese als wirkstoff enthält |
| US6982259B2 (en) * | 2002-04-30 | 2006-01-03 | Schering Aktiengesellschaft | N-heterocyclic derivatives as NOS inhibitors |
| ES2389253T3 (es) * | 2002-10-25 | 2012-10-24 | Zenyaku Kogyo Kabushiki Kaisha | Compuestos heterocíclicos y agentes antitumorales que comprenden los mismos como ingrediente activo |
| RU2265604C1 (ru) * | 2004-09-15 | 2005-12-10 | Кубанский государственный аграрный университет | 4,6-бис(морфолил)-2-[(2`-этоксиацетилтетразолил)-5`-ил]-1,3,5-триазин в качестве антидота |
| CA2590299A1 (en) * | 2004-12-13 | 2006-06-22 | Neurogen Corporation | Piperazinyl-pyridine analogues |
| AU2006221285B2 (en) | 2005-03-11 | 2011-03-31 | Zenyaku Kogyo Kabushikikaisha | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| US20070244110A1 (en) * | 2006-04-14 | 2007-10-18 | Zenyaku Kogyo Kabushiki Kaisha | Treatment of prostate cancer, melanoma or hepatic cancer |
| US20110053907A1 (en) * | 2008-03-27 | 2011-03-03 | Auckland Uniservices Limited | Substituted pyrimidines and triazines and their use in cancer therapy |
| WO2009125870A1 (en) * | 2008-04-09 | 2009-10-15 | Mitsubishi Tanabe Pharma Corporation | Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers. |
| GB2465405A (en) * | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
| AU2010223919B2 (en) | 2009-03-13 | 2016-03-31 | Les Laboratoires Servier | Methods and compositions for cell-proliferation-related disorders |
| CR20170071A (es) | 2009-06-29 | 2017-03-28 | Agios Pharmaceuticals Inc | Compuestos terapeuticos y composiciones |
| AR077999A1 (es) * | 2009-09-02 | 2011-10-05 | Vifor Int Ag | Antagonistas de pirimidin y triazin-hepcidina |
| CA2793835C (en) | 2009-10-21 | 2021-07-20 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
| CA2814120C (en) | 2010-10-27 | 2018-08-07 | The Walter And Eliza Hall Institute Of Medical Research | Novel anti-cancer agents |
| PH12013502241A1 (en) | 2011-05-03 | 2014-01-06 | Agios Pharmaceuticals Inc | Pyruvate kinase activators for use in therapy |
| CN102827170A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
| HUE038403T2 (hu) | 2012-01-06 | 2018-10-29 | Agios Pharmaceuticals Inc | Terápiásan alkalmazható vegyületek és alkalmazási módszereik |
| US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
| AU2013331626B2 (en) | 2012-10-15 | 2018-08-02 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| CN105473560B (zh) * | 2013-07-11 | 2020-01-17 | 安吉奥斯医药品有限公司 | 治疗活性化合物及其使用方法 |
| WO2015003355A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| WO2015003360A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| KR102302091B1 (ko) | 2013-07-11 | 2021-09-16 | 아지오스 파마슈티컬스 아이엔씨. | 암 치료용의 ｉｄｈ２ 돌연변이체 억제제로서의 ｎ,６-비스(아릴 또는 헤테로아릴)-１，３，５-트리아진-２,４-디아민 화합물 |
| CN105593215B (zh) | 2013-07-11 | 2019-01-15 | 安吉奥斯医药品有限公司 | 用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物 |
| US20150031627A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| UA121211C2 (uk) | 2014-03-14 | 2020-04-27 | Аджіос Фармасьютикалз, Інк. | Фармацевтична композиція, що містить тверду дисперсію, та спосіб лікування гострої мієлогенної/мієлоїдної лейкемії (гмл) |
| MA44392B1 (fr) | 2015-06-11 | 2023-10-31 | Agios Pharmaceuticals Inc | Procédés d'utilisation d'activateurs de la pyruvate kinase |
| HUE067449T2 (hu) | 2015-10-15 | 2024-10-28 | Servier Lab | Ivozidenib, citarabin és daunorubicin vagy idarubicin kombinációs terápa akut mielogén leukémia kezelésére |
| US10653710B2 (en) | 2015-10-15 | 2020-05-19 | Agios Pharmaceuticals, Inc. | Combination therapy for treating malignancies |
| JP7039370B2 (ja) * | 2018-04-06 | 2022-03-22 | 四国化成工業株式会社 | イミダゾリルトリアジン化合物及びその利用 |
| US10980788B2 (en) | 2018-06-08 | 2021-04-20 | Agios Pharmaceuticals, Inc. | Therapy for treating malignancies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3308122A (en) * | 1965-05-10 | 1967-03-07 | Dow Chemical Co | Trimidazolyl triazine compounds |
| JPS4917677B1 (enExample) * | 1970-12-30 | 1974-05-02 | ||
| JPS5655302A (en) * | 1979-10-15 | 1981-05-15 | Hokko Chem Ind Co Ltd | Fungicide for agriculture and horticulture |
| DE3611427A1 (de) * | 1986-04-05 | 1987-10-08 | Hoechst Ag | Bis-tertiaerbutylamino-substituierte 1,3,5-triazinderivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung |
-
1993
- 1993-02-26 US US08/290,870 patent/US5489591A/en not_active Expired - Fee Related
- 1993-02-26 WO PCT/JP1993/000240 patent/WO1993017009A1/ja not_active Ceased
- 1993-02-26 CA CA002131004A patent/CA2131004A1/en not_active Abandoned
- 1993-02-26 DE DE69322076T patent/DE69322076D1/de not_active Expired - Lifetime
- 1993-02-26 AU AU35751/93A patent/AU665238B2/en not_active Ceased
- 1993-02-26 EP EP93904356A patent/EP0629622B1/en not_active Expired - Lifetime
-
1994
- 1994-08-27 KR KR1019940703005A patent/KR950700282A/ko not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU3575193A (en) | 1993-09-13 |
| CA2131004A1 (en) | 1993-09-02 |
| EP0629622B1 (en) | 1998-11-11 |
| WO1993017009A1 (fr) | 1993-09-02 |
| EP0629622A4 (enExample) | 1995-01-18 |
| US5489591A (en) | 1996-02-06 |
| EP0629622A1 (en) | 1994-12-21 |
| DE69322076D1 (de) | 1998-12-17 |
| AU665238B2 (en) | 1995-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950700282A (ko) | S-트리아진 유도체 및 이를 활성성분으로서 함유하는 에스트로겐-의존성 질환 치료제(s-Triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient) | |
| DK0673240T3 (da) | Stabiliserede medicinske aerosolopløsningsformuleringer | |
| FI971776A7 (fi) | Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi | |
| NO933239D0 (no) | Bioeroderbar innretning for administering av aktive ingredienser | |
| FI950617A7 (fi) | Farmaseuttisesti aktiiviset diketopiperatsiinit | |
| PT589843E (pt) | Composicoes farmaceuticas contendo ciclosporinas | |
| FI973452L (fi) | Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen | |
| KR970006279A (ko) | 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물 | |
| FI944123L (fi) | Farmaseuttiset inhalaatiokoostumukset | |
| NO955107D0 (no) | Fungicide virkestoffkombinasjoner | |
| NO179941C (no) | Farmasöytisk forbindelse | |
| FI925778A0 (fi) | Farmaceutiskt aktiva bensokinazolinfoereningar | |
| KR950703855A (ko) | 곤충 및 응애류 방제용 상승작용성 제제(synergistic agents for controlling insects and mites) | |
| FI961437A7 (fi) | Vaikuttavan aineen luovuttava systeemi | |
| FI951306A7 (fi) | Otsoniystävällinen sterilointiaineseos | |
| DE59310333D1 (de) | Synergistisch wirksame Herbizidkombinationen | |
| KR950700911A (ko) | 살균약제로서의 치환된 3-피롤리디닐티오-카르바페넴(Substituted 3-Pyrrolidinylthio-Carbapenems as Antimicrobial Agents) | |
| FI20010074A7 (fi) | Terapeuttisesti aktiivisia 4-aryyli-3-(heteroaryyliureido)-1,2-dihydro-2-oksokinoliinijohdannaisia | |
| FI935228A7 (fi) | 2-alkoksi-2-imidatsoli-5-ooni-sienimyrkkyjohdannaiset | |
| KR950704292A (ko) | 약학적 활성을 가진 이환식 화합물(Bicycylic Compounds with Pharmaceutical Activity) | |
| DE69326721D1 (de) | Insektizidzusammensetzung | |
| KR960700233A (ko) | 헤테로고리 유도체 및 유해 생물 방제제(heterocyclic derivative and pest control agent) | |
| FI934387A7 (fi) | 3-substituoituja 2-oksi-indoli-1-karboksiamidia käsittäviä farmaseuttisia koostumuksia | |
| NO950731D0 (no) | Optisk aktive karboksamidderivater | |
| FI934360A7 (fi) | Benflumetolia sisältävät synergistiset malarialääkekoostumukset |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19940827 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19980225 Comment text: Request for Examination of Application |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19991220 |
|
| NORF | Unpaid initial registration fee | ||
| PC1904 | Unpaid initial registration fee |